MMX® mesalazine for the treatment of patients with ulcerative colitis: the impact of treatment on health related quality of life

被引：0
|
作者：
Kane, S. [1 ]
Yen, L. [2 ]
Yarlas, A. [3 ]
Karlstadt, R. [2 ]
Solomon, D. [2 ]
Hodgkins, P. [2 ]
机构：
[1] Mayo Clin, Dept Med, Rochester, MN USA
[2] Shire Pharmaceut Inc, Wayne, PA USA
[3] QualityMetric Inc, Lincoln, RI USA
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A92 / A92
页数：1
相关论文
共 50 条
  • [31] Treatment with MMX® mesalamine: compliance and clinical recurrence in patients with quiescent ulcerative colitis
    Kane, S.
    Solomon, D.
    Palmen, M.
    Barrett, K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A92 - A92
  • [32] Infliximab therapy improves health related quality of life in ulcerative colitis patients
    Feagan, BG
    Rutgeerts, P
    Hanauer, S
    Yan, S
    Eisenberg, D
    Johanns, J
    Olson, A
    Sandborn, WJ
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S293 - S294
  • [33] Effect of MMx-Mesalazine (Mezavant Xl®) in the Microbiological Profile of the Colon in Patients With Ulcerative Colitis
    Cusachs, J. Oriol Miquel
    Serra-Pages, Mariona
    Busquets, David
    Salavedra, Anna Bahi
    Garcia-Gil, Jesus
    Aldeguer, Xavier
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S453 - S453
  • [34] The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis
    Irvine, E. J.
    Yeh, C. -H.
    Ramsey, D.
    Stirling, A. L.
    Higgins, P. D. R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (11-12) : 1278 - 1286
  • [35] High adherence to treatment with MMX® Mesalazine
    Husen-Weiss, Eva
    [J]. VISZERALMEDIZIN, 2012, 28 (01): : 71 - 71
  • [36] Health-Related Quality of Life in Patients With Ulcerative Colitis After Treatment With Vedolizumab: Results From the Gemini 1 Study
    Feagan, Brian G.
    Colombel, Jean-Frederic
    Rubin, David T.
    Mody, Reema
    Sankoh, Serap
    Lasch, Karen
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S590 - S590
  • [37] Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis
    Agilli, Mehmet
    Dogan, Tolga
    Ergin, Giray
    [J]. INFLAMMATORY BOWEL DISEASES, 2015, 21 (08) : E14 - E15
  • [38] Health related quality of life and disease activity in patients with ulcerative colitis before and during high dose prednisolone treatment.
    Wilson, BV
    Lauritsen, K
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A124 - A124
  • [39] Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis
    Salice, Marco
    Rizzello, Fernando
    Calabrese, Carlo
    Hrustemovic, Hana Privitera
    Gionchetti, Paolo
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (07) : 607 - 613
  • [40] MMX® Mesalazine A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis
    Yang, Lily P. H.
    McCormack, Paul L.
    [J]. DRUGS, 2011, 71 (02) : 221 - 235
12345